The Trump administration on April 1 laid off the staff at several HIV prevention offices within the Centers for Disease Control and Prevention. These cuts include the offices responsible for public health communication campaigns, behavioral surveillance, and non-laboratory research.
These actions are part of broader layoffs in the Department of Health and Human Services (HHS) which have resulted in thousands of staff being reduced. The entire staffs of the HHS Office of Infectious Diseases & HIV Policy and the HHS Office of Minority Health have been eliminated.
The impact on HIV prevention is being felt by these staff cuts. Carl Schmid, executive director of the HIV+Hepatitis Policy Institute, stated, “The expertise of the staff, along with their decades of leadership, has now been destroyed and cannot be replaced. We will feel the impacts of these decisions for years to come, and it will certainly, sadly, translate into an increase in new HIV infections and higher medical costs.”
The administration’s restructuring also involved the reassignment of key personnel. Dr. Jonathan Mermin, former director of the National Center for HIV, Viral Hepatitis, STD, and TB Prevention, has been reassigned to the Indian Health Service. Similarly, Dr. Jeanne Marrazzo, director of the National Institute of Allergy and Infectious Diseases, has been moved to a position within the same service.
These developments have raised alarms among public health experts. The elimination of critical programs and the loss of experienced staff are expected to hinder efforts to prevent new HIV infections. The full impact of these cuts remains to be seen, but concerns are mounting about the potential reversal of progress made in combating HIV in the United States.
